Site(s) of metastases-Peritoneum Posts on Medivizor
Navigation Menu

Site(s) of metastases-Peritoneum Posts on Medivizor

The benefits of repeated cytoreductive surgery and hyperthermic peritoneal chemotherapy in advanced colorectal cancer

The benefits of repeated cytoreductive surgery and hyperthermic peritoneal chemotherapy in advanced colorectal cancer

Posted by on May 21, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the benefits of repeated cytoreductive surgery (CRS) and hyperthermic peritoneal chemotherapy (HIPEC) in patients with advanced colorectal cancer. Researchers suggested that repeated treatment improves the survival of patients with advanced colorectal cancer, without an increase in side effects. Some background...

Read More

What is the best treatment for patients with colorectal cancer and peritoneal metastasis?

Posted by on Sep 29, 2018 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) with other treatment options in patients with colorectal cancer (CRC) and peritoneal metastasis (PM; when cancer spreads to the abdominal lining). Researchers suggested that CRS + HIPEC brings the greatest...

Read More

Comparison of two treatments for colorectal cancer that has spread to the peritoneum

Posted by on Apr 27, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared two treatments for peritoneal metastasis in colorectal cancer (cancer that has spread to the lining of the abdomen).  Some background Peritoneal metastasis is a serious complication of colorectal cancer. It is not usually treatable with standard chemotherapy, which is injected into veins or given by...

Read More

Comparing two chemotherapy drugs for cancer that has spread to the peritoneum

Posted by on Mar 23, 2015 in Colorectal cancer | 0 comments

In a nutshell This study compared the outcome of patients with colorectal or appendix cancer that had spread to the peritoneum (the lining of the abdominal cavity). Some background Peritoneal metastasis indicates that the initial cancer has spread to the peritoneum. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) is...

Read More

Treatment options for patients with colorectal cancer that has spread to the peritoneum

Posted by on Feb 15, 2015 in Colorectal cancer | 0 comments

In a nutshell This study investigated two treatment options for patients with cancer that has spread to the peritoneum (the lining of the abdominal cavity). Some background A common location for colorectal cancer to spread is the peritoneum. The best way to treat patients with peritoneal invasion is with cytoreductive surgery plus intraperitoneal...

Read More

Evaluating the benefits of laparoscopy in determining the extent of peritoneal carcinomatosis for patients with colorectal cancer

Posted by on May 13, 2013 in Colorectal cancer | 0 comments

In a nutshell This article evaluated whether the use of a minimally invasive diagnostic technique called laparoscopy before surgery to treat peritoneal carcinomatosis improves the selection of patients who can benefit the most from treatment. The authors of the study found that laparoscopy can be used to select patients for whom surgery may be a...

Read More

Early post-operative intraperitoneal chemotherapy (EPIC) and hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) for cancers of the appendix, colon or rectum

Posted by on Apr 19, 2013 in Colorectal cancer | 0 comments

In a nutshell This study will compare two procedures to deliver chemotherapy into the abdominal cavity following surgery to remove colorectal cancer spread to the peritoneum (the lining of the abdominal cavity).  The primary outcome of the study is disease-free survival, or the length of time without any evidence of cancer. The details...

Read More

Risks versus benefit of the ‘HIPEC’ treatment for peritoneal metastases due to colorectal cancer

Posted by on Feb 24, 2013 in Colorectal cancer | 0 comments

Colorectal cancer (CRC) often presents with peritoneal metastases, which have a poor outcome. This means that cancer cells have spread from the colon, appendix, or rectum to the peritoneum (a sheath that covers the abdominal organs). This article argues the pros and cons of a combined treatment for patients with peritoneal metastases from CRC. This...

Read More